Audeara Advances AI Licensing and Auracast Rollout Amid Record FY26 Revenue

Record Revenue and Cash Receipts Highlight Growth

Audeara Ltd (ASX:AUA) closed FY26 with a record $4.2 million in cash receipts and unaudited revenue of $4.44 million, up from $3.79 million in FY25. The company’s Australian wholesale channel was a key driver, delivering $2.62 million for the year; a 46.4% increase on the prior corresponding period. Despite a net operating cash outflow of $415,000 for the full year, this marked the lowest cash burn in Audeara’s history, reflecting disciplined cost management amid strategic investments.

AI Audio Licensing Nears Commercial Production

Audeara’s chip-level AI audio licensing agreement with Optek Microelectronics advanced significantly in Q4, with the first customer program completing development and nearing commercial production. This milestone is critical as it validates Audeara’s scalable licensing model, which integrates proprietary AI noise reduction and media personalisation algorithms directly into semiconductor platforms. A second program is in final customer validation stages, potentially expanding fee-per-chip revenue streams without the need for Audeara to manufacture hardware.

Exclusive Assistive Listening Deal Targets Educational Market

The company secured exclusive Australian market deployment rights with Shokz Health Global for a customised assistive listening device branded OpenLearn Small. Tailored for children with functional listening challenges, the product addresses an estimated 600,000 Australian school-aged children affected by fluctuating hearing loss. The deal opens pathways into government-funded education programs and charitable channels, aiming for initial customer orders later this year. This partnership aligns with Audeara’s strategy to expand its hearing-health platform through collaborations with global hardware leaders.

Auracast Rollout Expands Across Retirement Communities

Audeara commenced what it believes to be a world-first large-scale Auracast™ rollout across Bolton Clarke’s 43 retirement villages, starting at Carrington Retirement Village in Queensland. The technology enables improved shared-listening experiences in community centres, addressing hearing loss that affects approximately 45% of residents. This deployment serves as a reference model for expanding Auracast solutions into healthcare, aged care, and community settings, reinforcing Audeara’s connected-listening strategy.

International Engagement and Technology Leadership Transition

On the international front, Audeara showcased its portfolio at major events including ACAud 2026, SusHi Tech Tokyo 2026, and the Asia Summit on Global Health, engaging stakeholders across healthcare and accessibility sectors in Australia, Japan, and the Asia-Pacific region. The company also signed a new Japanese distributor, Pola Digital, enhancing its market presence. Meanwhile, co-founder and CTO Alex Afflick transitioned from his full-time executive role, with a structured handover ensuring continuity across product development and licensing programs.

Outlook Focused on Commercial Conversion and Cash Discipline

Looking ahead to FY27, Audeara’s priorities include progressing Optek’s first customer program into commercial production, converting the ShokzHear agreement into sales, supporting the Bolton Clarke rollout, advancing Clinico white-label Auracast programs, and maintaining momentum in Australian wholesale channels. The company acknowledges that revenue timing will depend on customer validation cycles and partner-led commercialisation but remains focused on converting its technology portfolio into repeatable, scalable revenue streams while managing cash carefully. With $740,000 in cash and $1.047 million in financing facilities, Audeara retains flexibility to support growth initiatives.